Latest AI and machine learning research in allergy for healthcare professionals.
INTRODUCTION: Neurological illnesses continue to be a major global health challenge and require novel and safe therapeutic strategies. Blue foods like marine fish, algae, and invertebrates consist of many bioactive proteins/peptides that might provide multiple benefits for maintenance of a healthy brain, including neuroprotection, reduction of inflammation, and reduction of oxidative stress. This ...
BACKGROUND: KRAS-mutant lung adenocarcinoma (LUAD) is associated with aggressive phenotypes and therapy resistance, which highlights an urgent need to identify reliable biomarkers and therapeutic targets. This study aims to investigate the role of galactose metabolism (GM) reprogramming in shaping the tumor microenvironment (TME) and driving immunotherapy resistance in KRAS-mutant LUAD. METHODS: B...
Quantitative systems pharmacology (QSP) models support model-informed drug development but are computationally expensive, limiting workflows requiring...
BACKGROUND: Neoantigens-tumor-specific peptides generated by somatic mutations-are central targets of effective anticancer T cell immunity and underpi...
BACKGROUNDS: Breast cancer (BRCA) represents the most prevalent malignancy globally, with projections indicating 3.2 million new cases anticipated by ...
BACKGROUND: Colorectal cancer (CRC) is a prevalent malignant tumor with increasing incidence and mortality rates worldwide. Exosomes are secretory ves...
BACKGROUND: Hepatocellular carcinoma (HCC) is a highly lethal malignancy with poor prognosis, and effective biomarkers for predicting immunotherapy re...
BACKGROUND: Atopic dermatitis (AD) is a prevalent inflammatory skin disease and a major source of disease burden in children. Biomarker studies in chi...
The poor prognosis of high‑grade gliomas, such as glioblastoma, is largely driven by a notably immunosuppressive tumor microenvironment (TME), wherein...
BACKGROUND: The combination of immune checkpoint inhibitors (ICIs) and anti-angiogenic agents represents the standard first-line therapy for patients ...
BACKGROUND: Sepsis-induced acute respiratory distress syndrome (ARDS) is a life-threatening form of acute diffuse lung injury caused by sepsis. Howeve...
Messenger RNA-lipid nanoparticle (mRNA-LNP) therapeutics have emerged as a versatile drug modality, enabling in vivo protein expression for vaccines, ...
BACKGROUND: Black lung disease remains a major occupational health problem among coal miners and is frequently diagnosed at an advanced stage, limitin...
BACKGROUND: Asthma-COPD overlap (ACO) remains poorly characterized at the molecular level, leading to diagnostic uncertainty and suboptimal treatment....
Oncolytic viruses (OVs) represent a versatile platform for cancer immunotherapy, capable of selectively infecting and lysing tumor cells while trigger...
Childhood allergic asthma (CAA) is a chronic airway inflammatory disorder driven by allergens, and its underlying molecular mechanisms as well as prec...
OBJECTIVE: Lung adenocarcinoma (LUAD) molecular heterogeneity limits traditional prognostic models. Given the emerging role of neural regulation (NR) ...
Metastatic renal cell carcinoma remains clinically challenging because of heterogeneous outcomes and limited predictive biomarkers for immunotherapy. ...
BACKGROUND: Osteoarthritis (OA) is a chronic degenerative joint disease characterized by the progressive deterioration of articular cartilage, signifi...
PURPOSE: Antibody-drug conjugates (ADC) targeting trophoblast cell surface antigen 2 (TROP-2) and cMET are entering clinical trials in non-small cell ...